Search research articles
Contact Us
Filters
Showing results (421-430 of 520) with videos related to
Page
of 52
Sort By:
Seminars in Nuclear Medicine
|
February 4, 2009
Functional imaging of inflammatory diseases using nuclear medicine techniques
Sandip Basu, Hongming Zhuang, Drew A Torigian, et al.
Hellenic Journal of Nuclear Medicine
|
April 23, 2010
An original case of isolated unilateral adrenal metastasis from penile carcinoma: documentation by 18F-FDG-PET imaging and histopathology
Prathamesh Joshi, Mukta Joshi-Kulkarni, Sandip Basu, et al.
Hellenic Journal of Nuclear Medicine
|
November 26, 2009
Tumor metabolism measured by partial volume corrected standardized uptake value varies considerably in primary and metastatic sites in patients with lung cancer. A new observation
Gonca Bural, Drew A Torigian, Mohamed Houseni, et al.
Clinical Nuclear Medicine
|
July 14, 2020
Sequential Duo-Peptide Receptor Radionuclide Therapy With Indigenous 90Y-DOTATATE and 177Lu-DOTATATE in Large-Volume Neuroendocrine Tumors: Posttherapy Bremsstrahlung and PET/CT Imaging Following 90Y-DOTATATE Treatment
Rahul V Parghane, Arpit Mitra, Trupti Upadhye, et al.
Clinical Nuclear Medicine
|
June 12, 2013
Adverse functional effects of chemotherapy on whole-brain metabolism: a PET/CT quantitative analysis of FDG metabolic pattern of the "chemo-brain"
Jordan Sorokin, Babak Saboury, JinHyung Albert Ahn, et al.
Nuclear Medicine Communications
|
June 1, 2016
Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics
Pradeep Thapa, Rohit Ranade, Vikas Ostwal, et al.
Nuclear Medicine Communications
|
May 22, 2026
Efficacy of intra-arterial [177Lu]Lu-DOTATATE vs. continuation intravenous [177Lu]Lu-DOTATATE peptide receptor radionuclide therapy in nonresponding locally advanced inoperable or liver-dominant metastatic gastroenteropancreatic neuroendocrine tumors
Rangat Bagasariya, Rahul Vithalrao Parghane, Nitin Shetty, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 29, 2015
Clinical Efficacy and Safety Comparison of 177Lu-EDTMP with 153Sm-EDTMP on an Equidose Basis in Patients with Painful Skeletal Metastases
Pradeep Thapa, Dilip Nikam, Tapas Das, et al.
Nuclear Medicine Communications
|
January 2, 2024
Normal physiological distribution and tumor localization of 64 CuCl 2 in different human malignancies along with semiquantitative scoring: a comparative evaluation with 18 Fluorodeoxyglucose ( 18 FDG) PET-CT
Parth Baberwal, Sunita Sonavane, K V Vimalnath, et al.
Annals of Nuclear Medicine
|
April 16, 2009
A recovery coefficient method for partial volume correction of PET images
Shyam M Srinivas, Thiruvenkatasamy Dhurairaj, Sandip Basu, et al.
Page
of 52
Search research articles
Search
Showing results (421-430 of 520) with videos related to
Sort By:
Page
of 52
Seminars in Nuclear Medicine
|
February 4, 2009
Functional imaging of inflammatory diseases using nuclear medicine techniques
Sandip Basu, Hongming Zhuang, Drew A Torigian, et al.
Hellenic Journal of Nuclear Medicine
|
April 23, 2010
An original case of isolated unilateral adrenal metastasis from penile carcinoma: documentation by 18F-FDG-PET imaging and histopathology
Prathamesh Joshi, Mukta Joshi-Kulkarni, Sandip Basu, et al.
Hellenic Journal of Nuclear Medicine
|
November 26, 2009
Tumor metabolism measured by partial volume corrected standardized uptake value varies considerably in primary and metastatic sites in patients with lung cancer. A new observation
Gonca Bural, Drew A Torigian, Mohamed Houseni, et al.
Clinical Nuclear Medicine
|
July 14, 2020
Sequential Duo-Peptide Receptor Radionuclide Therapy With Indigenous 90Y-DOTATATE and 177Lu-DOTATATE in Large-Volume Neuroendocrine Tumors: Posttherapy Bremsstrahlung and PET/CT Imaging Following 90Y-DOTATATE Treatment
Rahul V Parghane, Arpit Mitra, Trupti Upadhye, et al.
Clinical Nuclear Medicine
|
June 12, 2013
Adverse functional effects of chemotherapy on whole-brain metabolism: a PET/CT quantitative analysis of FDG metabolic pattern of the "chemo-brain"
Jordan Sorokin, Babak Saboury, JinHyung Albert Ahn, et al.
Nuclear Medicine Communications
|
June 1, 2016
Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics
Pradeep Thapa, Rohit Ranade, Vikas Ostwal, et al.
Nuclear Medicine Communications
|
May 22, 2026
Efficacy of intra-arterial [177Lu]Lu-DOTATATE vs. continuation intravenous [177Lu]Lu-DOTATATE peptide receptor radionuclide therapy in nonresponding locally advanced inoperable or liver-dominant metastatic gastroenteropancreatic neuroendocrine tumors
Rangat Bagasariya, Rahul Vithalrao Parghane, Nitin Shetty, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 29, 2015
Clinical Efficacy and Safety Comparison of 177Lu-EDTMP with 153Sm-EDTMP on an Equidose Basis in Patients with Painful Skeletal Metastases
Pradeep Thapa, Dilip Nikam, Tapas Das, et al.
Nuclear Medicine Communications
|
January 2, 2024
Normal physiological distribution and tumor localization of 64 CuCl 2 in different human malignancies along with semiquantitative scoring: a comparative evaluation with 18 Fluorodeoxyglucose ( 18 FDG) PET-CT
Parth Baberwal, Sunita Sonavane, K V Vimalnath, et al.
Annals of Nuclear Medicine
|
April 16, 2009
A recovery coefficient method for partial volume correction of PET images
Shyam M Srinivas, Thiruvenkatasamy Dhurairaj, Sandip Basu, et al.
Page
of 52